FORTRESS BIOTECHPRFA (Germany) Performance
| CNB0 Stock | EUR 6.60 0.45 6.38% |
On a scale of 0 to 100, FORTRESS BIOTECHPRFA holds a performance score of 7. The firm shows a Beta (market volatility) of -0.0554, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning FORTRESS BIOTECHPRFA are expected to decrease at a much lower rate. During the bear market, FORTRESS BIOTECHPRFA is likely to outperform the market. Please check FORTRESS BIOTECHPRFA's sortino ratio, maximum drawdown, and the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether FORTRESS BIOTECHPRFA's price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in FORTRESS BIOTECHPRFA 25 are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile fundamental drivers, FORTRESS BIOTECHPRFA reported solid returns over the last few months and may actually be approaching a breakup point. ...more
FORTRESS |
FORTRESS BIOTECHPRFA Relative Risk vs. Return Landscape
If you would invest 535.00 in FORTRESS BIOTECHPRFA 25 on April 23, 2025 and sell it today you would earn a total of 125.00 from holding FORTRESS BIOTECHPRFA 25 or generate 23.36% return on investment over 90 days. FORTRESS BIOTECHPRFA 25 is generating 0.4547% of daily returns assuming 5.0053% volatility of returns over the 90 days investment horizon. Simply put, 44% of all stocks have less volatile historical return distribution than FORTRESS BIOTECHPRFA, and 91% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
FORTRESS BIOTECHPRFA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for FORTRESS BIOTECHPRFA's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as FORTRESS BIOTECHPRFA 25, and traders can use it to determine the average amount a FORTRESS BIOTECHPRFA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0908
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CNB0 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.01 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.45 actual daily | 9 91% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average FORTRESS BIOTECHPRFA is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of FORTRESS BIOTECHPRFA by adding it to a well-diversified portfolio.
FORTRESS BIOTECHPRFA Fundamentals Growth
FORTRESS Stock prices reflect investors' perceptions of the future prospects and financial health of FORTRESS BIOTECHPRFA, and FORTRESS BIOTECHPRFA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on FORTRESS Stock performance.
| Return On Equity | -1.43 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.17) % | |||
| Operating Margin | (2.63) % | |||
| Revenue | 77.61 M | |||
| EBITDA | (197.84 M) | |||
| Cash And Equivalents | 289.9 M | |||
| Cash Per Share | 2.98 X | |||
| Total Debt | 98.04 M | |||
| Debt To Equity | 0.40 % | |||
| Book Value Per Share | 0.57 X | |||
| Cash Flow From Operations | (83.48 M) | |||
| Earnings Per Share | (0.82) X | |||
About FORTRESS BIOTECHPRFA Performance
By analyzing FORTRESS BIOTECHPRFA's fundamental ratios, stakeholders can gain valuable insights into FORTRESS BIOTECHPRFA's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if FORTRESS BIOTECHPRFA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if FORTRESS BIOTECHPRFA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.Things to note about FORTRESS BIOTECHPRFA performance evaluation
Checking the ongoing alerts about FORTRESS BIOTECHPRFA for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for FORTRESS BIOTECHPRFA help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| FORTRESS BIOTECHPRFA had very high historical volatility over the last 90 days | |
| FORTRESS BIOTECHPRFA has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 77.61 M. Net Loss for the year was (42.98 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| FORTRESS BIOTECHPRFA 25 has accumulated about 289.9 M in cash with (83.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.98. |
- Analyzing FORTRESS BIOTECHPRFA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether FORTRESS BIOTECHPRFA's stock is overvalued or undervalued compared to its peers.
- Examining FORTRESS BIOTECHPRFA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating FORTRESS BIOTECHPRFA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of FORTRESS BIOTECHPRFA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of FORTRESS BIOTECHPRFA's stock. These opinions can provide insight into FORTRESS BIOTECHPRFA's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for FORTRESS Stock analysis
When running FORTRESS BIOTECHPRFA's price analysis, check to measure FORTRESS BIOTECHPRFA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FORTRESS BIOTECHPRFA is operating at the current time. Most of FORTRESS BIOTECHPRFA's value examination focuses on studying past and present price action to predict the probability of FORTRESS BIOTECHPRFA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FORTRESS BIOTECHPRFA's price. Additionally, you may evaluate how the addition of FORTRESS BIOTECHPRFA to your portfolios can decrease your overall portfolio volatility.
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |